Dunno if it'll matter, but I can't remember ever opening the earnings news and seeing as many "MISSES" and "ISSUES DOWNWARD GUIDANCE" remarks as this:
finance.yahoo.com
Anybody know how to get it to highlight "MISSES" and "DOWNWARD" in this post?
4:59PM Overhill Farms declines proposal from potential acquirer (OFI) 4.17 -0.08 : Co announces that it has declined a proposal submitted jointly by GESD Capital Partners and Citicorp Venture Capital to acquire all of the co's stock for $4.40/share. "The Board believes that the co's present performance and its prospects for both immediate and long-term future revenue and profitability growth justify a significantly higher valuation for the co than any of the proposals received to date."
4:57PM Cephalon gives statement on Federal Trade Commission action regarding PROVIGIL patent settlements (CEPH) 57.40 -1.03 : Co issues statement in response to a complaint filed by U.S. Federal Trade Commission challenging the validity of certain agreements entered into by the company in late 2005 and early 2006 to settle the PROVIGIL patent infringement litigation and seeking to permanently enjoin the co from maintaining or enforcing these agreements. Co stands by the strength and validity of our PROVIGIL patents and the legal basis for these settlements. Co is disappointed that the FTC has determined to challenge these agreements as it believes fully comply with both the spirit and letter of the antitrust laws. As importantly, settlements confer a meaningful benefit to U.S. consumers by providing for the entry of generic modafinil three years early. Co is prepared to vigorously defend itself in this matter and expects to prevail.
4:55PM LivePerson beats by $0.03, misses on revs; guides Q1 EPS in-line, revs below consensus; guides FY08 EPS below consensus, revs below consensus (LPSN) 3.80 -0.01 : Reports Q4 (Dec) earnings of $0.09 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.06; revenues rose 63.1% year/year to $16.8 mln vs the $17 mln consensus. Co issues in-line EPS guidance for Q1, sees EPS of $0.04-0.05 vs. $0.04 consensus; sees Q1 revs of $17.3-17.5 mln vs. $17.75 mln consensus. Co issues downside guidance for FY08, sees EPS of $0.20-0.21 vs. $0.24 consensus; sees FY08 revs of $77-79 mln vs. $79.19 mln consensus.
4:54PM Genco Shipping & Trading beats by $0.14, reports revs in-line (GNK) 55.09 +4.77 :
4:50PM Avis Budget beats by $0.09, misses on revs (CAR) 11.66 -0.24 : Reports Q4 (Dec) earnings of $0.27 per share, excluding non-recurring items, $0.09 better than the First Call consensus of $0.18; revenues rose 4.1% year/year to $1.39 bln vs the $1.41 bln consensus. The Company projects that its revenue, EBITDA and pretax income for full year 2008 will increase compared to 2007 revenue of $6.0 billion (FY08 rev consensus $6.11 bln), EBITDA of $409 million and pretax income of $198 million, excluding unusual items.
4:49PM Drew Industries misses by $0.01, missed on revs (DW) 26.11 +1.55 : Reports Q4 (Dec) earnings of $0.29 per share, $0.01 worse than the First Call consensus of $0.30; revenues were slightly down (~ flat) year/year to $137.8 mln vs the $142.7 mln consensus.
4:49PM First Place Finl announces the appointment of David Gifford to the position of Chief Financial Officer (FPFC) 13.85 -0.24 :
4:47PM Photronics beats by $0.02, beats on revs (PLAB) 11.88 : Reports Q1 (Jan) loss of $0.08 per share, $0.02 better than the First Call consensus of ($0.10); revenues fell 2.5% year/year to $103.2 mln vs the $101.8 mln consensus.
4:45PM West Pharm concludes agreement with Nektar (WST) 38.01 -0.30 : Co announces that it has concluded an agreement with Nektar Therapeutics (NKTR) relating to the manufacture and assembly of components for the Exubera inhalable insulin device. Production of the device was suspended in October 2007 following Pfizer, (PFE) decision to discontinue marketing the product, returning the marketing rights to the co's customer, Nektar. Financial terms of the agreement were not disclosed.
4:41PM Techtarget misses by $0.02, beats on revs; guides Q1 revs in-line (TTGT) 13.41 +0.25 : Reports Q4 (Dec) earnings of $0.06 per share, $0.02 worse than the First Call consensus of $0.08; revenues rose 22.8% year/year to $28.4 mln vs the $28.1 mln consensus. Co issues in-line guidance for Q1, sees Q1 revs of $23-24 mln vs. $23.59 mln consensus.
4:41PM Heartland Payment Systems misses by $0.05, misses on revs; guides FY08 EPS below consensus, revs below consensus (HPY) 25.06 +0.81 : Reports Q4 (Dec) earnings of $0.22 per share, excluding non-recurring items, $0.05 worse than the First Call consensus of $0.27; revenues rose 18.6% year/year to $341.6 mln vs the $345.7 mln consensus. Co issues downside guidance for FY08, sees EPS of $1.13-1.17 vs. $1.26 consensus; sees FY08 revs growth of 16-18%, which equates to ~$1.52-1.55 bln vs. $1.56 bln consensus.
4:41PM Advance America Cash misses by $0.04, misses on revs; announces additional $75 mln share buyback (AEA) 8.65 +0.21 : Reports Q4 (Dec) earnings of $0.16 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.20; revenues fell 1.1% year/year to $183.6 mln vs the $188.9 mln consensus.
4:41PM Tortoise Energy Infrastructure announces commencement of common stock offering of ~1.5 mln shares (TYG) 34.00 +0.29 :
4:40PM Core Labs beats by $0.01, reports revs in-line; guides Q1 EPS in-line, revs in-line; guides FY08 EPS below consensus, revs above consensus (CLB) 118.15 +3.74 : Reports Q4 (Dec) earnings of $1.36 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $1.35; revenues rose 15.4% year/year to $176.4 mln vs the $176.8 mln consensus. Co issues in-line guidance for Q1, sees EPS of $1.34-1.37 vs. $1.37 consensus; sees Q1 revs of approx $180 mln vs. $177.70 mln consensus. Co issues mixed guidance for FY08, sees EPS of $5.75-6.00 vs. $6.09 consensus; sees FY08 revs of $770-780 mln vs. $760.05 mln consensus.
4:38PM Baidu.com beats by $0.16, beats on revs; guides Q1 revs below consensus (BIDU) 261.09 +15.66 : Reports Q4 (Dec) earnings of $0.87 per share, $0.16 better than the First Call consensus of $0.71; revenues rose 125.0% year/year to $78.3 mln vs the $77.1 mln consensus. Co issues downside guidance for Q1, sees Q1 revs of $73.1-75.1 mln vs. $77.01 mln consensus.
4:37PM Polypore Intl beats by $0.06; sees FY08 EPS and rev above consensus (PPO) 17.74 +0.06 : Reports Q4 (Dec) earnings of $0.27 per share, $0.06 better than the First Call consensus of $0.21; revenues rose 16.2% year/year to $145.1 mln vs the $133.5 mln consensus. Co issues upside guidance; sees FY08 EPS of $0.86-0.96 vs $0.82 consensus; sees revs of $545-565 mln v s $543.9 mln consensus.
4:36PM Opexa Therapeutics announces the pricing of public offering of 3.5 mln shares of common stock at $2.00 (OPXA) 1.84 -0.53 :
4:36PM iPass reports EPS in-line, beats on revs; guides Q1 EPS in-line, revs below consensus (IPAS) 3.01 +0.01 : Reports Q4 (Dec) earnings of $0.02 per share, in-line with the First Call consensus of $0.02; revenues rose 10.6% year/year to $50 mln vs the $48.8 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.02-$0.05 vs. $0.04 consensus; sees Q1 revs of $47.5-$50.5 mln vs. $50.06 mln consensus.
4:35PM Stamps.com beats by $0.01, misses on revs; guides FY08 EPS in-line, revs below consensus (STMP) 11.02 +1.02 : Reports Q4 (Dec) earnings of $0.16 per share, $0.01 better than the First Call consensus of $0.15; revenues fell 3.2% year/year to $24.1 mln vs the $24.9 mln consensus. Co issues mixed guidance for FY08, sees EPS of $0.60-$0.70 vs. $0.70 consensus; sees FY08 revs of $80-$90 mln vs. $96.60 mln consensus.
4:34PM EastGroup beats by $0.02, misses on revs (EGP) 42.17 -0.92 : Reports Q4 (Dec) funds from operations of $0.86 per share, $0.02 better than the First Call consensus of $0.84; revenues rose 12.0% year/year to $38.5 mln vs the $39 mln consensus.
4:30PM Xinhua Finance misses by $0.04, beats on revs; guides Q1 revs below consensus; guides FY08 revs in-line (XFML) 4.88 +0.30 : Reports Q4 (Dec) earnings of $0.14 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.18; revenues rose 101.2% year/year to $48.5 mln vs the $46.7 mln consensus. Co issues downside guidance for Q1, sees Q1 revs of $25-30 mln vs. $41.53 mln consensus. Co issues in-line guidance for FY08, sees FY08 revs of $190-200 mln vs. $190.50 mln consensus.
4:22PM Advance Auto misses by $0.03, misses on revs; guides FY08 EPS below consensus, revs below consensus (AAP) 35.43 +0.34 : Reports Q4 (Dec) earnings of $0.35 per share, $0.03 worse than the First Call consensus of $0.38; revenues rose 3.1% year/year to $1.05 bln vs the $1.07 bln consensus. Co issues downside guidance for FY08, sees EPS of $2.55 vs. $2.64 consensus; sees FY08 revs of $5.1 bln vs. $5.16 bln consensus. The guidance for 2008 fiscal year is based on the prevailing economic environment where the Company believes it is prudent to forecast comparable store sales to be flat until Company trends demonstrate consistent and sustainable improvement.
4:22PM KBR Inc.'s Granherne awarded frame agreement by StatoilHydro ASA (KBR) 31.91 +0.86 : Co announces that it has been awarded a three year frame agreement by StatoilHydro ASA (STO) to provide conceptual engineering services for the development of oil and gas resources in the Gullfaks Area of the Norwegian continental shelf. Co will provide consulting engineering services to evaluate potential processing scenarios for the optimization of StatoilHydro's process systems and infrastructure.
4:19PM DaVita misses by $0.02, beats on revs (DVA) 54.19 +0.19 : Reports Q4 (Dec) earnings of $0.79 per share, $0.02 worse than the First Call consensus of $0.81; revenues rose 6.4% year/year to $1.36 bln vs the $1.33 bln consensus. "Our operating income guidance for 2008, excluding the impact of any potential Medicare legislation, is still projected to be in the range of $790-850 million; however, we continue to believe that operating income is more likely to be in the lower end of the range for 2008. We are entering into a period of unusual earnings uncertainty. Therefore, the guidance range for 2008 does not capture as high a percentage of the potential outcomes as usual."
4:19PM Bally Technologies beats by $0.03, beats on revs; guides FY08 EPS in-line (BYI) 45.87 +1.34 : Reports Q2 (Dec) earnings of $0.42 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.39; revenues rose 52.9% year/year to $230.7 mln vs the $199.1 mln consensus. Co issues in-line guidance for FY08, sees EPS of $1.62-1.87 vs. $1.78 consensus, prior guidance $1.60-1.90.
4:18PM Mobility Elec beats by $0.03, beats on revs; guides Q1 EPS in-line (MOBE) 1.09 -0.01 : Reports Q4 (Dec) earnings of $0.01 per share, $0.03 better than the First Call consensus of ($0.02); revenues rose 5.2% year/year to $20.3 mln vs the $16.5 mln consensus. Co issues in-line guidance for Q1, sees EPS of ($0.01)- $0.00 vs. ($0.01) consensus.
4:18PM ValueClick beats by $0.03, beats on revs; guides Q1 EPS below consensus, revs below consensus; guides FY08 EPS below consensus, revs in-line (VCLK) 21.68 +0.88 : Reports Q4 (Dec) earnings of $0.21 per share, ex itens, vs the First Call consensus of $0.18; revenues rose 14.2% year/year to $183.1 mln vs the $175.8 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.15-$0.16 vs. $0.18 consensus; sees Q1 revs of $166-$170 mln vs. $175.45 mln consensus. Co issues mixed guidance for FY08, sees EPS of $0.78-$0.81 vs. $0.82 consensus; sees FY08 revs of $730-$745 mln vs. $740.24 mln consensus. In an effort to settle this matter, VCLK has agreed to a settlement payment of $2.9 mln without an admission of liability or conceding that the company violated any laws.
4:18PM Covad misses by $0.03, misses on revs (DVW) 0.85 +0.01 : Reports Q4 (Dec) loss of $0.04 per share, $0.03 worse than the First Call consensus of ($0.01); revenues fell 0.2% year/year to $121.6 mln vs the $125 mln consensus. Due to the pending acquisition of DVW by Platinum, which is expected to close in Q2, DVW will not provide financial guidance for 2008.
4:17PM Callwave misses by $0.01, misses on revs (CALL) 2.79 -0.02 : Reports Q2 (Dec) loss of $0.07 per share, $0.01 worse than the First Call single analyst est of ($0.06); revenues fell 29.4% year/year to $4.9 mln vs the $5.3 mln single analyst est.
4:16PM TranSwitch announces stock repurchase program of up to $10 mln (TXCC) 0.64 0.00 :
4:16PM Thomas Weisel beats by $0.15, reports revs in-line (TWPG) 10.96 +0.37 : Reports Q4 (Dec) earnings of $0.13 per share, excluding non-recurring items, $0.15 better than the First Call consensus of ($0.02); revenues rose 0.5% year/year to $76.9 mln vs the $76.7 mln consensus.
4:16PM Red Lion Hotels: Arthur Coffey to retire as President and CEO; Anupam Narayan named new President and CEO (RLH) 7.80 +0.08 :
4:15PM Nighthawk Radiology reports EPS in-line, revs in-line; guides FY08 EPS below consensus, revs below consensus (NHWK) 14.15 +0.28 : Reports Q4 (Dec) earnings of $0.26 per share, in-line with the First Call consensus of $0.26; revenues rose 77.2% year/year to $42.7 mln vs the $42.5 mln consensus. Co issues downside guidance for FY08, sees EPS of $1.10-1.20 vs. $1.25 consensus; sees FY08 revs of $195-205 mln vs. $211.89 mln consensus.
4:15PM Amerigroup reports EPS in-line, revs in-line; raises FY08 EPS in-line (AGP) 36.29 -0.76 : Reports Q4 (Dec) earnings of $0.57 per share, in-line with the First Call consensus of $0.57; revenues rose 32.0% year/year to $1.05 bln vs the $1.05 bln consensus. Co raises guidance in-line for FY08, sees EPS of $2.58-2.73 vs. $2.59 consensus, up from $2.45-2.60.
4:15PM The Knot beats by $0.01, misses on revs (KNOT) 13.89 +0.00 : Reports Q4 (Dec) earnings of $0.08 per share, $0.01 better than the First Call consensus of $0.07; revenues rose 11.3% year/year to $24.2 mln vs the $24.9 mln consensus. Co also says Gross profit margins for the 12 months ended December 31, 2007 were 82% as compared to 79% in 2006.
4:14PM Agilent beats by $0.01, beats on revs; guides Q2 EPS below consensus, revs in-line (A) 32.68 +0.83 : Reports Q1 (Jan) earnings of $0.42 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.41; revenues rose 8.8% year/year to $1.39 bln vs the $1.38 bln consensus. Co issues downside EPS guidance for Q2, sees EPS of $0.46-0.50 vs. $0.53 consensus; sees Q2 revs of $1.4-1.45 bln vs. $1.43 bln consensus.
4:14PM Ingram Micro beats by $0.01, beats on revs; guides Q1 EPS below consensus, revs below consensus (IM) 17.49 -0.61 : Reports Q4 (Dec) earnings of $0.61 per share, $0.01 better than the First Call consensus of $0.60; revenues rose 13.0% year/year to $10.01 bln vs the $9.86 bln consensus. Co issues downside guidance for Q1, sees EPS of $0.36-$0.40 vs. $0.44 consensus; sees Q1 revs of $8.75-$9.0 vs. $9.11 bln consensus. "We are experiencing some softness in Europe and North America, which is reflected in our guidance, but Asia-Pacific and Latin America remain strong. Our strategic investments are an advantage in this environment by providing geographic, market-segment and business-model diversity.
4:14PM NETGEAR misses by $0.04, reports revs in-line; guides Q1 revs below consensus (NTGR) 26.87 +0.97 : Reports Q4 (Dec) earnings of $0.41 per share, excluding non-recurring items, $0.04 worse than the First Call consensus of $0.45; revenues rose 20.9% year/year to $198.3 mln vs the $199.4 mln consensus. Co issues downside guidance for Q1, sees Q1 revs of $201-205 mln vs. $207.42 mln consensus. "We expect normal seasonality in Q1 2008. Specifically, we expect first quarter net revenue to be approximately $201-205 million, with non-GAAP operating margin in the range of 11-12%. Finally, we expect the non-GAAP effective tax rate to be approximately 39%."
4:13PM Molina Healthcare beats by $0.07, reports revs in-line; guides FY08 EPS in-line (MOH) 33.55 +0.26 : Reports Q4 (Dec) earnings of $0.63 per share, $0.07 better than the First Call consensus of $0.56; revenues rose 22.0% year/year to $670.6 mln vs the $670.6 mln consensus. Co issues in-line guidance for FY08, sees EPS of $2.25-2.45 vs. $2.34 consensus.
4:12PM Zymogenetics beats by $0.14, beats on revs (ZGEN) 9.14 -0.01 : Reports Q4 (Dec) loss of $0.56 per share, $0.14 better than the First Call consensus of ($0.70); revenues rose 369.6% year/year to $20.5 mln vs the $6.3 mln consensus. Co issues guidance for FY08, sees FY08 revs of $35-45 mln, excluding Recothrom sales, may not be comparable to $77.00 mln consensus.
4:11PM Skechers USA misses by $0.03, misses on revs; guides Q1 EPS in-line, revs above consensus (SKX) 21.28 +1.07 : Reports Q4 (Dec) earnings of $0.26 per share, $0.03 worse than the First Call consensus of $0.29; revenues fell 0.8% year/year to $302 mln vs the $310.9 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.57-$0.62 vs. $0.58 consensus; sees Q1 revs of 385-395 vs. $382.85 mln consensus.
4:10PM Regions Fincl names Irene Esteves Senior Executive VP and CFO; CFO Al Yother to retire in April (RF) 23.59 -0.12 :
4:10PM Amkor beats by $0.18, beats on revs; guides Q1 EPS above consensus, revs above consensus (AMKR) 9.37 +0.85 : Reports Q4 (Dec) earnings of $0.46 per share, $0.18 better than the First Call consensus of $0.28; revenues rose 9.4% year/year to $747 mln vs the $700 mln consensus. Co issues upside guidance for Q1, sees EPS of $0.25-0.29 vs. $0.23 consensus; sees Q1 revs down 7-9% q/q, which equates to approx $680-695 mln vs. $676.10 mln consensus.
4:10PM XTO Energy announces common stock offering of 20 mln shares (XTO) 56.61 +0.63 :
4:10PM Network Appliance beats by $0.03, reports revs in-line; guides Q4 EPS below consensus, revs below consensus (NTAP) 23.04 +1.51 : Reports Q3 (Jan) earnings of $0.37 per share, $0.03 better than the First Call consensus of $0.34; revenues rose 21.2% year/year to $884 mln vs the $877.8 mln consensus. Co issues downside guidance for Q4, sees EPS of $0.35-0.37 vs. $0.38 consensus; sees Q4 revs of $915-945 mln vs. $966.48 mln consensus.
4:07PM ValueClick announces settlement with the FTC; agrees to pay a settlement of $2.9 million (VCLK) 21.68 +0.88 :
4:06PM Bell Micro announces receipt of waivers from its major lenders (BELM) 4.81 -0.16 : The co announces it has received waivers under all of the Company's major lending agreements. Wachovia Capital Finance Corporation, Wachovia Bank, Bank of America, and the Retirement Systems of Alabama, have all agreed to waive the company's obligation to provide audited financial statements through September 30, 2008, and, where applicable, the requirement that the Company remain listed on NASDAQ.
4:06PM Intersil: CEO Rich Beyer resigns; David Bell named CEO (ISIL) 23.95 +0.22 :
4:05PM Acxiom announces increase in stock repurchase program by $25 mln (ACXM) 12.10 +0.30 :
4:04PM Gen-Probe beats by $0.06, reports revs in-line; guides FY08 EPS in-line, revs below consensus (GPRO) 58.62 +0.39 : Reports Q4 (Dec) earnings of $0.37 per share, $0.06 better than the First Call consensus of $0.31; revenues rose 8.6% year/year to $98.9 mln vs the $98.8 mln consensus. Co issues mixed guidance for FY08, sees EPS of $1.64-1.72 vs. $1.70 consensus; sees FY08 revs of $443-453 mln vs. $456.30 mln consensus.
4:03PM Bally Technologies selected by Harrah's to provide casino management, marketing systems internationally (BYI) 45.87 +1.34 : Co announces that Harrah's Entertainment (HET) has extended its domestic relationship with Bally to provide key casino slot and gaming management and marketing systems for Harrah's international operations. The transaction is subject to Harrah's corporate approvals, execution of definitive agreements, and receipt of required regulatory approvals.
4:01PM Watson Pharm announces FDA inspection of Florida facilities (WPI) 26.79 +0.51 : The co announces that the FDA has initiated an inspection of the company's Florida facilities. No information regarding the duration or outcome of the inspection is known. Since September 2005, the Davie, Florida manufacturing facility has been under Official Action Indicated. During that time, Watson has continued to file Abbreviated New Drug Applications for product candidates to be manufactured at this site. However, FDA approval of pending ANDAs has been withheld pending positive resolution of the OAI status. While a resolution to the OAI status may enable product candidates to be approved, it does not ensure that any such ANDAs will be approved or, if approved, will be launched. The OAI status does not affect manufacture of products at the Davie, Florida facility that have already been approved for manufacture at that facility, nor does it affect Watson's other locations.
4:01PM DaVita announces Richard Whitney has rejoined and will be appointed Chief Financial Officer (DVA) 54.12 +0.12 : Co announces that Richard Whitney has rejoined and will be appointed Chief Financial Officer effective March, 1, 2008. Rich will be working with DaVita in a part-time role that is expected to go on for 1 to 2 years.
4:00PM Nighthawk Radiology announces departure of Tim Mayleben, President and COO and the departure of Senior VP and CFO Glenn Cole (NHWK) 14.15 +0.28 :
3:45PM General Steel files for a 5.38 mln share offering by selling shareholders, pursuant to a resale of common stock issued in the form of convertible notes (GSI) 8.17 -0.14 :
3:42PM Earnings Calendar : Today after the close look for the following companies to report: AWA, AAP, A, MDRX, AGP, AMKR, AGII, CAR, BIDU, BYI, COG, CCRT, OFC, DVW, DENN, EGP, EAC, EQIX, FARO, GPRO, GSIC, HS, HIMX, IPAS, MHK, NTGR, NTAP, NHWK, PVA, PLAB, RMKR, STMP, TTGT, KNOT, VCLK, VMC, and ZGEN. Tomorrow before the open look for the following companies to report: EYE, ALXN, AUXL, BRY, CTL, CMCSA, DSCO, ENZN, FCL, GTIV, GOL, GT, KONA, CLI, MAR, MESA, MNTA, NRP, NXY, NTMD, OPXT, ORB, PTEN, PDS, QMAR, SPAR, STFC, SSYS, TASR, VNDA, and VC. Click here for a complete list of all the companies scheduled to report.
3:31PM Conferences and Shareholder/Analyst Meetings of Interest : Events of interest tomorrow, February 14, include: PNX Investor Day; SE Analyst Meeting; ARTG at Credit Suisse Group Software Conf; CNI, CP, WNC, NSC, AAWW at BB&T Capital Markets Transportation Services Conf; IPQ, FTRS, NFEI, MCF, AEZ, AREX at Independent Petroleum Association of America OGIS Small Cap Conf; SMSC, SAIA, PWAV, PSYS, ALGN at Deutsche Bank Small- and Mid-Cap Growth Conf.
2:35PM Nymex Energy Closing Prices (COMDX) : Crude closed the session up 44 cents to $93.22pbl, nat gas settled lower by 6.7 cents to $8.369mbtu, heating oil ended up by 2.51 cents to $2.6162/gal and RBOB finished higher by 1.94 cents to $2.3874.
2:30PM N. American Galvanizing reports Q4 EPS of $0.17 vs $0.08, revs were flat YoY to $20.2 mln (NGA) 5.94 +0.40 :
1:57PM Questar announces Charles B. Stanley has been promoted to chief operating officer effective March 1, 2008. (STR) 53.62 -0.21 :
1:37PM Comex Metals Closing Prices (COMDX) : Gold closed the session off 40 cents to $910.70/oz, silver settled up 10 cents to $17.350/oz and copper finished lower by 2.5 cents to $3.5350/lb.
1:36PM Martek Biosci life'sDHA now featured in two new flavors of Rachel's Wickedly Delicious Yogurt from WhiteWave Foods (MATK) 29.22 +0.67 :
1:23PM VistaCare: Accipiter Capital Management reaffirms its opposition to the acquisition of VistaCare by Odyssey Healthcare (VSTA) 8.55 -0.02 : Accipiter Capital Management, the owner, together with its affiliates, of nearly 10% of the outstanding shares of common stock of VistaCare, (VSTA), announced it had delivered a letter to VistaCare's Board of Directors stating that a review of VistaCare's Quarterly Report for the quarterly period ended Dec 31, 2007, has further convinced Accipiter that the offer by Odyssey Healthcare (ODSY) to acquire VistaCare for $8.60 per share is wholly inadequate. The letter further indicated that Accipiter was troubled by inconsistencies between VistaCare's internal analysis of the co's restructuring and information VistaCare's management disclosed to investors. The letter calls on VistaCare's Board of Directors to explain these inconsistencies to stockholders and urges stockholders not to tender their shares in connection with the acquisition and to exercise their appraisal rights to the full extent permissible under law should the tender offer and subsequent merger be consummated.
1:20PM Stryker announces authorization to purchase $750 mln in common stock (SYK) 69.73 +0.65 :
1:03PM VSE Corp wins FT fuels research & testing contract with USAF (VSEC) 24.88 +0.27 : Co announces recent award of a U.S. Air Force subcontract supporting the Advanced Power Technology Office to research, demonstrate and sustain the incorporation of Fischer-Tropsch (F-T) fuel in diesel engines. Under a two-year subcontract agreement with Concurrent Technologies Corporation, I.C.R.C will provide technical support to facilitate the testing of ultra-clean F-T fuel blended with conventional petroleum-derived JP-8. This 50:50 blend will be evaluated in base storage facilities, Air Force ground support equipment, and Air Force ground vehicles. Potential I.C.R.C revenues under the subcontract are estimated to be $1.38 mln over a two year period.
12:21PM Oneida Financial announces 250K buyback (ONFC) 10.25 -0.01 :
12:05PM Morgan Stanley to scale back residential mortgage businesses (MS) 42.19 -0.52 : Co announces that it will scale back its residential mortgage operations in the U.S. in response to the continued deterioration of the mortgage markets. In addition, the firm will discontinue its UK-based residential mortgage lending business, Advantage Home Loans. Approx 1,000 employees in the U.S. and the UK will be affected by this restructuring. Morgan Stanley will continue to service mortgage loans in the U.S. through its Saxon Mortgage Services, Inc. platform, based in Fort Worth, Texas. In addition, the Firm will still offer residential mortgages to its retail brokerage clients through Morgan Stanley Credit Corporation, preserving a successful partnership between the Institutional Securities business and Global Wealth Management.
12:01PM O.I. Corporation announces reduction in size of board of directors to 5 from 7 (OICO) 10.20 -0.33 :
11:05AM Trintech Group announces agreement to acquire Movaris (TTPA) 2.50 -0.07 : Co announces the signing of a definitive agreement to acquire Movaris, Inc., a venture-backed company located in San Jose, California. The transaction is expected to be accretive to income on an EBITDA basis (Earnings before Interest, Tax, Depreciation and Amortization) for the fiscal year ending January 31, 2009. The consideration for the acquisition will be satisfied through the payment of $5 mln cash and the issuing of 1.25 mln Trintech American Depositary Shares, or at the option of Movaris shareholders the cash equivalent value of such ADSs, plus a potential contingent payment in early 2010 based on the trading price of our ADSs prior to such date.
10:38AM JDA Software and Sirius form strategic alliance (JDAS) 17.97 +0.38 : Co announces the formation of a strategic alliance with Sirius Computer Solutions. As a preferred provider of IBM hardware, Sirius will actively market JDA Software's products and services to customers and prospects seeking new or additional business applications to improve their performance and competitiveness. Similarly, JDA Software will recommend Sirius as its preferred provider of IBM's world-class hardware solutions. This synergy will not only deliver significant value to each company's respective customers, but will also enable both Sirius and JDA Software to expand their solution offering and marketing efforts to existing and new customers.
10:24AM Globecomm Systems awarded infrastructure contract valued at $3.8 mln from a major satellite service provider in Asia (GCOM) 9.96 +0.03 :
10:24AM Triumph Group increases stock repurchase program with additional 500,000 shares of its common stock (TGI) 58.29 +1.41 :
10:04AM Diodes reports EPS in-line, revs in-line; guides Q1 revs below consensus (DIOD) 22.82 -0.46 : As mentioned at 10:01 co reports Q4 (Dec) earnings of $0.43 per share, in-line with the First Call consensus of $0.43; revenues rose 14.0% year/year to $107.6 mln vs the $107.9 mln consensus. Co issues downside guidance for Q1, sees Q1 revs of $95-101 mln vs. $104.56 mln consensus. Co also says gross margin will be comparable to Q4. "Our estimated first quarter revenue reflects seasonality combined with the impact of the overall weakening economy, in particular on key targeted end-equipment in the consumer and computing markets, as well as our foundry and subcontracting business, which is showing greater weakness than our core revenue drivers. Over the longer-term, we believe that Diodes' history of execution in significantly outperforming the industry, combined with our focus on customer-centric innovation and efficient manufacturing, will return us to our historical growth rates and will continue to deliver positive results for our shareholders. Additionally, we remain focused on evaluating synergistic, accretive acquisition targets in the coming quarter and beyond to further drive increased value and profitable growth for Diodes."
9:53AM Healthways announces it has delivered a letter to Kerry Weems, Acting Administrator of CMS with respect to the Company's performance in its MHS Phase I Pilot (HWAY) 46.10 -0.54 : Co announces it has delivered a letter to Kerry Weems, Acting Administrator of the CMS with respect to the co's performance in its MHS Phase I Pilot in Maryland and the District of Columbia. In the letter, Healthways calls into question both the content and the conclusions, as they relate to Healthways, of several CMS documents distributed by CMS on January 29 to Congress, the press and the financial community. "The purpose of our communication with Acting Administrator Weems," Leedle stated, "was to affirmatively remind CMS that performance in MHS must be evaluated at the individual pilot, or pilot component level, not in the aggregate. Further, we continue to have a number of unresolved issues related to the design, beneficiary selection, randomization and other aspects of the Phase I pilots, including the fact that CMS did not deliver the pilot population that it was contractually obligated to provide. While ultimate resolution of these issues will impact the final results of our pilot, we believe, based on our analysis of the data that has been provided to us, our program or its components will meet or exceed the statutory and current Cooperative Agreement targets by which MHS performance is to be evaluated. This level of performance is not surprising to us given that every metric we use to evaluate the operational execution of our programs is exceeding the targets we set specifically for MHS." The letter also addressed any Beneficiary confusion or concern that CMS' announcements may have caused by informing CMS that, "Until the planned completion in July of the Phase I pilot program, we will continue to pursue the objectives outlined in the statute and Cooperative Agreement for the nearly 16,000 program participants for whom we are making a profound, meaningful and important difference in their lives."
9:45AM Sirius Satellite and Chrysler Extend Exclusive Relationship (SIRI) 3.12 +0.02 : The co and Chrysler announces an agreement that extends SIRIUS' exclusive relationship with Chrysler through Sept 2017. All Chrysler LLC brands -- Chrysler, Jeep and Dodge -- are covered by the agreement
9:32AM Allied Defense receives ammunition orders for approx $43.5 mln (ADG) 6.70 +0.00 : Co announces its Belgium-based ammunition subsidiary, MECAR S.A., has received orders totaling approx $43.5 mln. The orders have been placed by a new client in the Middle East, and call for the delivery of MECAR's 105mm tank ammunition over a three year period. (Briefing.com note: ADG's market cap is approx $54.2 mln)
9:31AM Implant Sciences executes letter of intent to acquire Ion Metrics (IMX) 1.04 +0.04 : Co announced the execution of a binding letter of intent to acquire Ion Metrics ("Ion Metrics"). In connection with this transaction, the Co plans to acquire all the assets of Ion Metrics, including its mass spectrometer technology, differential mobility spectrometer technology, ion mobility spectrometry technology, miniature, light weight vacuum pump technology, patents, manufacturing fixtures, and other related technological capabilities. The Co will also be assuming certain specified liabilities. The Co plans to issue 2 mln shares of its common stock as consideration for the transaction. The common stock to be issued will be restricted pursuant to the provisions of Securities and Exchange Commission Rule 144. The acquisition is subject to the execution of a definitive purchase agreement, which is expected to occur no later than March 31, 2008, and the satisfaction of other conditions which are customary in these types of transactions.
9:31AM L-1 Identity Solutions eeceives $3.7 mln contract to modernize Panama's national and voter registration ID system (ID) 13.25 +0.00 : Under the terms of the $3.7 mln contract, L-1 Identity Solutions, the prime contractor of the project, will deliver a complete multi-biometric solution that includes new enrollment devices, an upgrade of the biometric national registry, and integration services. The solution includes DFR 2100 Single Fingerprint Readers for fingerprint capture, ABIS System Search Engine for face and fingerprint image searches and BioTouch 500 and BioLogon Software for administrator authentication.
9:30AM Progen announces that 70% of the 55 patients recruited to PI-88 trial had decrease in serum Prostate Specific Antigen of greater than 50% (PGLA) 1.80 +0.10 : Co announces positive preliminary efficacy results from a phase 2 investigator-initiated trial of PI-88 in combination with the chemotherapeutic agent Taxotere administered to patients with prostate cancer. Co says 70% of the 55 patients recruited to the trial had a decrease in serum Prostate Specific Antigen of greater than 50% for three weeks or longer. These efficacy results compare favourably with the pivotal TAX327 Taxotere registration trial, where 45% of patients had at least a 50% decrease in serum PSA level. The trial concluded enrollment early due to a higher-than-expected rate of febrile neutropaenia, a side effect involving a decrease in white blood cells with associated fever. This is a known side effect of Taxotere, but was seen in this trial at a substantially greater rate than is generally considered typical for that drug.
9:27AM On The Wires (WIRES) : The Shaw Group (SGR) announces that its Environmental & Infrastructure Group has been awarded task orders by the Naval Facilities Engineering Command Southwest Division and the Naval Facilities Engineering Service Center in Port Hueneme, Calif... Cubist Pharmaceuticals(CBST) announces that its financial results for 2007 will incorporate a $1.2 mln charge to Q4 that was not included in the unaudited financial information released on Jan 23, 2008. This charge will be included in the financial statements to be filed in the company's form 10-K.
9:27AM Newspaper Notable Mentions (WIRES) : FT: BP and Rosneft have begun an indefinite "lull" in drilling off Sakhalin island, BP said on Tuesday as it admitted the exploration programme in the region "hasn't been the huge success that some thought it might be"... Globe and Mail: Coventree once the largest non-bank arranger of asset-backed commercial paper in Canada, said Tuesday it expects to "seek an orderly windup of its operations" and will distribute to shareholders of any remaining funds... WSJ: JNJ is voluntarily recalling a version of its blockbuster pain patch Duragesic because of manufacturing issues that could lead to accidental overdoses... Fujifilm Holdings said it would pay as much as $1.4 bln to acquire midsize drug maker Toyama Chemical, in a deal that represents the photography co's biggest push yet into medical products to drive its growth.
9:15AM S&P futures vs fair value: +9.8. Nasdaq futures vs fair value: +21.2. :
9:04AM CombiMatrix: Federal Court awards CBMX $31.4 mln in lawsuit against National Union Fire Ins. Co. (CBMX) 8.35 : The United States District Court for the Central District of California has issued a ruling in favor of CBMX and its former parent company. The Court awarded CombiMatrix and its former parent company $31,381,474 in monetary damages, to be paid by their insurance carrier, National Union Fire Ins. Co. of Pittsburgh, PA, which had refused to defend and indemnify CombiMatrix under its director and officer's insurance policy with National Union. In accordance with an agreement between CombiMatrix and its former parent company, all proceeds from the lawsuit will be paid to CombiMatrix.
9:03AM Cryocor says US PTO grants its request for patent interference (CRYO) 2.00 : Co announces that the United States Patent and Trademark Office has declared a patent interference between a patent application exclusively licensed by CryoCor and two patents held by CryoCath Technologies. The patent interference is related to certain pre-cooling technologies that CRYO considers important to CryoCath's cryoablation system. The USPTO designated CRYO to be the senior party in the interference as its patent application was found to predate CryoCath's original patent applications.
9:03AM Progressive's January net premiums written down 3% y/y (PGR) 18.40 : Co anounces that net premiums written for Jan were down 3% YoY, while net premiums earned were lower by 3% YoY.
9:02AM S&P futures vs fair value: +9.0. Nasdaq futures vs fair value: +22.0. : A higher start is expected, as futures continue to hold onto most of their post retail sales data boost. Crude oil is trading basically flat ahead of the government's weekly energy inventory report at 10:30 ET.
9:02AM Smart Modular Tech to acquire Adtron Corporation for $20 mln in cash (SMOD) 7.50 : Co announced that it signed a definitive agreement to acquire privately-held Adtron Corporation, a designer and global supplier of high performance and high capacity solid state flash disk drives. Under the terms of the agreement, which has been approved by the boards of directors of both companies, this all cash transaction is valued at approximately $20 mln with up to an additional $15 mln should certain calendar year 2008 financial and operational performance goals be achieved. The acquisition is expected to close on or about February 15, 2008.
8:57AM Belo misses by $0.05, reports revs in-line (BLC) 13.45 : Reports Q4 (Dec) earnings of $0.32 per share, excluding non-cash charge to goodwill, $0.05 worse than the First Call consensus of $0.37; revenues fell 6.8% year/year to $406.7 mln vs the $403.8 mln consensus. "As for first quarter 2008, total television revenues are currently pacing down low single digits when compared with first quarter 2007. As for full year 2008 guidance, we expect total revenues to be up in the mid-to-high single digits, depending on the strength of political in our markets and the stability of the economy."
8:51AM DIRECTV beats by $0.01, beats on revs (DTV) 23.88 : Reports Q4 (Dec) earnings of $0.30 per share, $0.01 better than the First Call consensus of $0.29; revenues rose 16.6% year/year to $4.88 bln vs the $4.76 bln consensus. Co reports US Net Subscriber Adds of 275k and Latin America Net Subscriber Adds of 199k. Co reports average monthly churn declined to 1.42%.
8:44AM Hospitality Props beats by $0.04, misses on revs (HPT) 34.51 : Reports Q4 (Dec) funds from operations of $1.15 per share, $0.04 better than the First Call consensus of $1.11; revenues rose 28.7% year/year to $326.8 mln vs the $345.3 mln consensus.
8:38AM Genzyme misses by $0.01, beats on revs; guides FY08 EPS in-line, revs above consensus (GENZ) 76.72 : Reports Q4 (Dec) earnings of $0.91 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of $0.92; revenues rose 21.4% year/year to $1.04 bln vs the $1.01 bln consensus. Co issues in-line guidance for FY08, sees EPS of $4.00, excluding non-recurring items, vs. $4.00 consensus; sees FY08 revs of $4.5-4.7 bln vs. $4.33 bln consensus.
8:37AM Cybex beats by $0.02, beats on revs (CYBI) 4.48 : Reports Q4 (Dec) earnings of $0.17 per share, $0.02 better than the First Call consensus of $0.15; revenues rose 16.5% year/year to $44.5 mln vs the $43.7 mln consensus.
8:37AM Daktronics beats by $0.02, beats on revs; guides Q4 (Apr) EPS in-line, revs in-line (DAKT) 19.48 : Reports Q3 (Jan) earnings of $0.13 per share, $0.02 better than the First Call consensus of $0.11. Co issues in-line guidance for Q4 (Apr), sees EPS of 0.12-0.19 vs. $0.19 consensus; sees Q4 (Apr) revs of 130-138 vs. $137.30 mln consensus. "Non-operating income included extra interest costs related to sales tax audits concluded during the quarter, a $2.8 mln gain on the sale of our interest in Arena Media Networks and a larger than expected loss on our share of earnings in FuelCast Networks as we expanded the network and saw sales less than expected. We expect this to turn around in calendar year 2008 as FuelCast further develops its advertising revenues."
8:36AM Ciber reports EPS in-line, beats on revs; guides Q1 EPS in-line, revs above consensus; guides FY08 EPS in-line, revs above consensus (CBR) 4.74 : Reports Q4 (Dec) earnings of $0.12 per share, in-line with the First Call consensus of $0.12; revenues rose 12.8% year/year to $290.5 mln vs the $283.4 mln consensus. Co issues guidance for Q1, sees EPS of $0.11-0.12 vs. $0.12 consensus; sees Q1 revs of $275-280 mln vs. $270.35 mln consensus. Co issues guidance for FY08, sees EPS of $0.53-0.57 vs. $0.53 consensus; sees FY08 revs of $1.120-1.140 bln vs. $1.11 bln consensus.
8:36AM Female Health reports Q1 EPS of $0.03 vs ($0.01) in 1Q07; revs rose 37% YoY to $5.7 mln - no ests (FHC) 2.44 : "We are very pleased to report strong revenue growth, a record number of female condoms sold and the highest quarterly profit in the Company's history for the three months ended December 31, 2007... "The 37% revenue increase reflects the growing role that our female condoms are playing in the global battle against HIV/AIDS. Acceptance of our second-generation FC2 Female Condom(R) has been excellent."
8:36AM On The Wires (WIRES) : Phoenix Technologies (PTEC) and SupportSoft (SPRT) announce a plan to develop the industry's first remote PC management solution that would allow users to continue running key productivity applications while the Windows operating system is being remotely diagnosed and repaired... Spire (SPIR) announces that it has been awarded United States Patent Number 7,306,963 entitled "Precision Synthesis of Quantum Dot Nanostructures for Fluorescent and Optoelectronic Devices."
8:35AM NGAS Resources announces year-end proved reserves Of 105 BCFE (NGAS) 5.24 : Co announces that its estimated proved reserves at year-end 2007 were 105 bln cubic feet equivalents ("Bcfe"), of which 46% were proved developed. Based on annualized fourth quarter production, the reserve life index at the end of 2007 was 28.8 years overall and approximately 13.1 years for the co's proved developed producing reserves. A majority of the acreage in the co's major fields is undeveloped, providing a multi-year inventory of drilling locations for future development.
8:32AM S&P futures vs fair value: +10.9. Nasdaq futures vs fair value: +21.5. : Futures get a lift on better than expected retail sales data. The Dept. of Commerce said January retail sales rose 0.3%, compared the expected decline of 0.3%. Excluding autos, sales rose 0.3%, compared to the expected rise of 0.2%.
8:32AM Pitney Bowes announces Michael Monahan has been named EVP and CFO (PBI) 37.17 : Co announces, effective March 1, Michael Monahan has been named EVP and Chief Financial Officer.
8:31AM Bentley Pharm announces product approvals in Europe (BNT) 15.39 : Co announces that its European subsidiaries have received approvals to market their omeprazole capsule products, through their licensees, in various territories in Europe. The co plans to begin supplying omeprazole to licensees during the first quarter of 2008.
8:30AM OptionsXpress announces $100 mln share repurchase; says DARTs for Jan were 41,200 (OXPS) 25.11 : Co announces that its Board of Directors has authorized a share repurchase program for up to $100 mln of the co's outstanding common stock. For Jan 2008, co says it had DARTs of 41,200 - 40% higher than January 2007, 19% higher than December 2007. Net new customer accounts of 4,900. Ending client assets of $5.4 billion
8:10AM On The Wires (WIRES) : MasterCard Worldwide and USA Technologies (USAT) announce the expansion of ePort cashless payment terminals to 17,500 vending machines nationwide, adding more than 4,000 new locations that accept MasterCard PayPass contactless payments... Bankers Petroleum (BNK) provides an operational update for its Albanian heavy oil operations and its United States exploration program... Suntech Power Holdings (STP) announces the opening of a sales office in South Korea to accelerate Suntech's business development and broaden local customer service capabilities... Hecla Mining (HL) and Independence Lead Mines (announced that they have signed an agreement for Hecla to acquire substantially all of the assets of Independence Lead Mines Co, located in northern Idaho's Silver Valley... Kaiser Aluminum (KALU) announces that its Board of Directors has approved $14 mln in additional investments to enhance and expand extrusion capabilities at its Tulsa, Okla., and Sherman, Texas, facilities, and deploy "future state" upgrades to the casting complex at its Trentwood facility... Sun Capital Securities Group announces the successful completion of Cardinal Integrated cash tender offer for the outstanding shares of Kellwood (KWD), which expired at 12:00 midnight New York City time, on Tuesday, February 12, 2008... Curtiss-Wright (CW) announces that it has entered into a multi-year agreement valued at over $16 mln from Saab Aerostructures to provide the large cargo door mechanical actuation system for the new Boeing (BA) 787 Dreamliner.
8:06AM E*TRADE total January DARTs increased 19% m/m (ETFC) 4.98 : Co released its monthly activity report for January. Total Daily Average Revenue Trades increased 19% month over month and nearly 22% year over year to 212K. The company increased net new retail accounts by 16K in the month - demonstrating the continued strength of the E*TRADE brand and its continued appeal to retail investors. End of period retail accounts totaled 4.7 mln, up 0.3% month over month and 6.2% year over year. Total retail client assets, which includes customer cash and securities holdings, declined 8.4% month over month and 12.3 percent year over year to $174 bln.
8:04AM CVS Corp and Universal American will end Medicare part d strategic alliance at year-end 2008 (CVS) 40.06 : CVS and Universal American (UAM) announce that their strategic alliance covering the Prescription Pathway Medicare Part D prescription drug plan program will end as of December 31, 2008, subject to regulatory approvals. Since the inception of the program in 2006, Universal American has offered Medicare Part D prescription drug plans through its Prescription Pathway products in conjunction with Caremark Pharmacy Services. CVS Caremark and Universal American stated that this change will not affect the Prescription Pathways Part D plan offerings in 2008 in which approximately 550,000 members are currently enrolled.
8:03AM Jazz Tech explores strategic alternatives to enhance stockholder value (JAZ) 1.12 : Co announces it has initiated a review of strategic alternatives to enhance stockholder value. To assist the company in its analysis and consideration of various strategic alternatives, the board of directors has retained UBS Securities LLC as its financial adviser.
8:03AM Possis Medical sees Q2 EPS of $0.03-0.05 vs $0.04 First Call consensus; revs $20.6 mln vs $19.05 mln First Call consensus (POSS) 19.35 :
8:02AM Vonage beats by $0.04, misses on revs (VG) 2.03 : Reports Q4 (Dec) loss of $0.06 per share, excluding non-recurring items, $0.04 better than the First Call consensus of ($0.10); revenues rose 19.0% year/year to $215.9 mln vs the $219.4 mln consensus.
8:02AM Voltaire renews OEM contract with IBM through 2010 and introduces two new products into the IBM BladeCenter product portfolio (VOLT) 5.60 :
8:01AM VMware unveils major program enhancements for its nearly 10,000 virtualization channel partners (VMW) 62.50 : Co announced major enhancements to the VMware VIP Partner Program. The enhancements, effective immediately, help make it easier for partners to quickly establish or expand their virtualization practices and offer customers increased value.
8:00AM GlobalOptions Group awarded $1.12 million in contracts from N.J. Counties (GLOI) 1.70 : Co announces that it has been awarded $1.12 mln in contracts to prepare multi-jurisdictional hazard mitigation plans and other related services for Union, Middlesex, Camden, Gloucester, Salem and Cumberland Counties in New Jersey.
8:00AM S&P futures vs fair value: +4.5. Nasdaq futures vs fair value: +12.5. : Stock futures point to a modestly higher start to the trading session. Better than expected reports from Coca-Cola (KO), Waste Management (WMI) and Applied Materials (AMAT) are helping to give the market support. January retail sales are set for release by the Dept. of Commerce at 8:30 ET. Economists expected sales to decrease by 0.3%, although they do expect a 0.2% rise when excluding autos.
7:54AM Geo Group beats by $0.01, beats on revs; reaffirms Q1, Q2, Q3, Q4, and Y08 guidance (GEO) 24.00 : Reports Q4 (Dec) earnings of $0.27 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.26; revenues rose 6.1% year/year to $262.6 mln vs the $252.9 mln consensus. GEO reaffirms Q1, Q2, Q3, Q4, and Y08 guidance. Co reaffirms guidance for Q1, sees EPS of $0.25-0.27, excluding non-recurring items, vs. $0.26 consensus; sees Q1 revs of $240-245 mln vs. $254.76 mln consensus. Co reaffirms guidance for Q2 (Jun), sees EPS of $0.30-0.32, excluding non-recurring items, vs. $0.31 consensus; sees Q2 (Jun) revs of $245-250 mln vs. $263.67 mln consensus. Co reaffirms guidance for Q3, sees EPS of $0.33-0.35, excluding non-recurring items, vs $0.33 consensus; sees revs of $255-260 mln vs $274.77 mln consensus. Co reaffirms guidance for Q4, sees EPS of $0.39-0.41, excluding non-recurring items, vs $0.39 consensus; sees revs of $270-275 mln vs $283.99 mln consnesus. Co reaffirms guidance for FY08, sees EPS of $1.27-1.35, excluding non-recurring items, vs. $1.29 consensus; sees FY08 revs of $1.01-1.03 bln vs. $1.08 bln consensus.
7:47AM Cytori Therapeutics receives first Celution 800 System orders in Europe and Asia; Begins commercialization into the reconstructive surgery market (CYTX) 5.40 : Co announces its first orders from Europe and Asia for Celution 800 Systems. The devices are now being sold into the growing international reconstructive surgery market. Eleven Celution 800 Systems and related CT-805 single-use consumables were ordered by Cytori's distributors MBA Grupo, who covers Spain, Italy, and Portugal, and Astrea International, who covers Singapore. The first devices are expected to be delivered in 1Q08.
7:43AM Acergy awarded $195 mln contract award in Canada (ACGY) 17.98 : Co announces the award of a $195 mln E.P.I.C. contract from EnCana for offshore installation SURF work on the Deep Panuke field located offshore Halifax, Nova Scotia, Canada.
7:40AM Acergy announces $150 mln deepwater contract award in Australia (ACGY) 17.98 :
7:38AM MGIC Investment reports Q4 (Dec) loss of $1.47 bln, misses on revs (MTG) : Reports Q4 (Dec) loss of $18.77 per share, may not be comparable to the First Call consensus of ($6.77); revenues rose 8.7% year/year to $399.1 mln vs the $416.1 mln consensus. Included in the quarterly results is the establishment of a pre-tax premium deficiency reserve of approximately $1.2 billion relating to Wall Street bulk transactions. The premium deficiency reserve reflects the present value of expected future losses and expenses that exceeded the present value of the expected future premium and already established loss reserves for these bulk transactions. Also included in the quarterly results is an after-tax charge of $33 million related to equity losses incurred by C-BASS in the fourth quarter that reduced the carrying value of the $50 million note from C-BASS to zero. New insurance written in the fourth quarter was $24.0 billion, compared to $15.5 billion in the fourth quarter of 2006.
7:35AM Dean Foods misses by $0.03, beats on revs; guides Q1 EPS below consensus; issues FY08 EPS guidance (DF) 26.93 : Reports Q4 (Dec) earnings of $0.27 per share, excluding non-recurring items, $0.03 worse than the First Call consensus of $0.30; revenues rose 24.6% year/year to $3.23 bln vs the $3.08 bln consensus. Co issues downside guidance for Q1, sees EPS of $0.15-0.20 vs. $0.25 consensus. Co issues guidance for FY08, sees EPS of at least $1.20 vs. $1.44 consensus.
7:33AM TASER announces 3 more product liability lawsuit dismissals (TASR) 11.53 : Co announces the dismissal with prejudice of the wrongful death product liability lawsuits filed against TASER International in the following cases: Fernandez v. TASER International, et al. filed in the United States District Court for the Northern District of California; LeBlanc v. TASER International, filed in the United States District Court for the Central District of California; and Moreno v. TASER International, filed in the Superior Court of the State of California, Los Angeles County, Central District.
7:32AM Ariad Pharm announces that it has promoted Richard Pascoe to the new position of chief operating officer (ARIA) 3.36 :
7:31AM Inspire Pharm initiates second phase 3 cystic fibrosis trial (ISPH) 3.97 : Co announces the initiation of TIGER-2, its second pivotal Phase 3 clinical trial with denufosol tetrasodium inhalation solution for the treatment of cystic fibrosis. TIGER-1, Inspire's first Phase 3 study with denufosol for cystic fibrosis, completed enrollment in October 2007 and the co expects to report top-line efficacy results for this initial trial mid-2008.
7:17AM Coca-Cola beats by $0.03, beats on revs (KO) 59.92 : Reports Q4 (Dec) earnings of $0.58 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.55; revenues rose 23.6% year/year to $7.33 bln vs the $7.01 bln consensus.
7:13AM RADA Electronic Industries receives a $2.7 mln production order from a strategic customer for the production of digital video recorders, cameras and debriefing stations (RADA) 2.08 :
7:12AM Waste Mgt beats by $0.03, beats on revs; guides FY08 EPS in-line (WMI) 33.13 : Reports Q4 (Dec) earnings of $0.54 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.51; revenues rose 2.4% year/year to $3.36 bln vs the $3.31 bln consensus. Co issues in-line guidance for FY08, sees EPS of $2.19-2.23 vs. $2.21 consensus; co sees internal rev growth on base business from yield of 2.5-3.0%; sees internal rev growth from volume down 2.5-3.0%.
7:11AM Deere beats by $0.05, beats on revs (DE) 86.48 : Reports Q1 (Jan) earnings of $0.83 per share, $0.05 better than the First Call consensus of $0.78; revenues rose 17.5% year/year to $5.2 bln vs the $5.07 bln consensus. Company equipment sales are projected to increase by about 17 percent for full-year 2008 and to be up approximately 23 percent for the second quarter. Currency accounts for approximately 3 percent of the sales increase for both periods. Deere's net income is forecast to be about $2.2 billion for the year and in a range of $700 million to $725 million for the second quarter.
7:09AM First Solar beats by $0.24, beats on revs (FSLR) 175.56 : Reports Q4 (Dec) earnings of $0.77 per share, $0.24 better than the First Call consensus of $0.53; revenues rose 26.3% year/year to $200.8 mln vs the $179.6 mln consensus. "During the fourth quarter of 2007 we benefited from the full capacity and economies of scale of our Frankfurt/Oder plant. This combined with continued throughput and conversion efficiency gains afforded us strong operating leverage and decreased our manufacturing cost per watt by 12% year over year to $1.12 per watt in the fourth quarter of 2007, further solidifying our cost leadership position in the industry."
7:09AM Novamed misses by $0.05, reports revs in-line (NOVA) 3.86 : Reports Q4 (Dec) earnings of $0.03 per share, $0.05 worse than the First Call consensus of $0.08.
7:06AM Jones Apparel beats by $0.02, misses on revs; guides FY08 EPS below consensus (JNY) 15.45 : Reports Q4 (Dec) earnings of $0.09 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.07; revenues fell 16.7% year/year to $838.5 mln vs the $874.8 mln consensus. Co issues downside guidance for FY08, sees EPS of $1.25-1.50, excluding non-recurring items, vs. $1.54 consensus.
7:04AM Max Capital Group announces increase in share repurchase plan up to $100 mln (MXGL) 28.50 :
7:03AM LaBarge receives $2.2 mln contract from Raytheon for JSOW program (LB) 14.36 : Co announces it has been awarded a $2.2 mln contract from Raytheon Missile Systems to continue to provide complex cable harnesses for the JSOW system.
7:02AM Acorda Therapeutics announces pricing of public offering of common stock of 3.3 mln shares at $21.50 (ACOR) 21.54 :
7:01AM Investools announces brokerage and education metrics for january 2008; new accounts opened of 8,050 (SWIM) 12.46 : Co announces performance metrics for January 2008. "Investools posted significant growth in our brokerage business, demonstrating the confidence that educated investors place in our trading platforms to help them navigate this volatile period in the financial markets. thinkorswim's 48,500 Retail DARTs represent an all-time record, and our 8,050 new accounts represent a strong start for 2008." thinkorswim new accounts opened were of 8050, total accounts opened of 132225, 148% higher than January 2007. New funded accounts of 3675, 58% higher than January 2007.
7:01AM Cubic Awarded $18.7 mln for virtual small arms training systems for U.S. Army and National Guard (CUB) 27.73 : Co announces it has received a $18.7 mln order for Engagement Skills Trainer 2000 small arms training systems and simulated weapons for the U.S. Army and the Army National Guard. EST 2000, validated by the U.S. Army Infantry School, teaches marksmanship skills, squad-level collective defense, and judgmental "shoot-don't shoot" tactics.
7:00AM Labopharm'S once-daily Tramadol approved in South Korea and Australia (DDSS) 2.59 : Co announces that its once-daily tramadol product has received regulatory approval from the Korea Food and Drug Administration, which allows for the marketing and sale of Labopharm's once-daily tramadol product in South Korea, and from the Australian Department of Health and Aging, which allows for the marketing and sale of Labopharm's once-daily tramadol product in Australia.
6:50AM Answers cancels public offering (ANSW) 4.92 : Co announces the termination of the proposed public offering of its common stock, due to unfavorable market conditions. The agreement to acquire Lexico will expire on March 1, 2008. Founder and CEO Robert S. Rosenschein explained, "Due to the state of public markets, we were unable to complete our proposed public offering.
6:43AM S&P futures vs fair value: +2.8. Nasdaq futures vs fair value: +13.5. :
6:41AM Journal Commun reports EPS in-line, misses on revs (JRN) 8.25 : Reports Q4 (Dec) earnings of $0.19 per share, excluding non-recurring items, in-line with the First Call consensus of $0.19; revenues fell 15.8% year/year to $147.6 mln vs the $150.7 mln consensus. For the first quarter of 2008, Journal Communications currently anticipates that its publishing revenues will be down compared to the prior year, reflecting continued challenges in classified advertising, partially offset by continued strength in online, commercial printing and commercial distribution. Both radio and television revenues are expected to be down slightly.
6:28AM S&P futures vs fair value: +2.8. Nasdaq futures vs fair value: +13.5. :
6:28AM European Markets : FTSE...5865.50...-44.50...-0.8%. DAX...6935.09...-32.75...-0.5%.
6:28AM Asian Markets : Nikkei...13068.30...+46.34...+0.4%. Hang Seng...23169.55...+247.88...+1.1%.
6:22AM eDiets.com announces an agreement with GlaxoSmithKline (DIET) 4.86 : Co announces an agreement with GlaxoSmithKline (GSK) Consumer Healthcare eDiets to provide customized meal delivery plans specifically designed for use with the market-leading alli product for weight loss.
6:19AM Jacada announces $10 mln share repurchase program (JCDA) 3.48 :
6:15AM Opnext announces expected restatement of financial statements (OPXT) 5.54 : Co announces that in the course of preparing their financial statements for the quarter ended December 31, 2007, the co has determined that errors occurred in the valuation of inventory consigned to one of its contract manufacturers and that, as a result, inventory and trade payables balances and the reported amounts of cost of goods sold and other income expense, net, were not properly reported for each of the fiscal years ended March 31, 2006 and March 31, 2007, and for the affected quarterly periods in each of those years. OPXT estimates that, as a result of the errors, net income was overstated by approx $1.8 mln for the fiscal year ended March 31, 2007 and its net loss was understated by approx $1.0 mln for the fiscal year ended March 31, 2006. In addition, net income was overstated by approx $0.7 mln for the three-month period ended December 31, 2006 and was understated by approx $0.1 mln for the three-month period ended September 30, 2006, while net loss was understated by approx $0.5 mln for the three-month period ended June 30, 2006. OPXT expects to file an amendment to its 10-K for the fiscal year ended March 31, 2007 to restate the previously issued audited financial statements for the years ended March 31, 2007 and March 31, 2006.
6:10AM Genesee & Wyoming beats by $0.06, beats on revs (GWR) 27.12 : Reports Q4 (Dec) earnings of $0.40 per share, excluding discontinued operations, $0.06 better than the First Call consensus of $0.34; revenues rose 14.3% year/year to $134.5 mln vs the $125.7 mln consensus.
6:05AM Gerdau AmeriSteel beats by $0.04, beats on revs; announces $0.25 special dividend (GNA) 13.19 : Reports Q4 (Dec) earnings of $0.37 per share, $0.04 better than the First Call consensus of $0.33; revenues rose 66.9% year/year to $1.73 bln vs the $1.65 bln consensus. On Feb. 12, co's Board approved a special cash dividend of $0.25 per common share, payable March 13, 2008 to shareholders of record at the close of business on February 28, 2008.
5:52AM Cam Commerce Solutions reports Q108 results (CADA) 40.85 : Reports Q1 (Dec) earnings of $0.39, $0.01 better than the First Call consensus fo $0.38; revenues rose 37% year/year to $9.85 mln vs the $9.37 mln consensus.
5:47AM Nice Systems beats by $0.01, reports revs in-line; guides Q1 EPS in-line, revs above consensus; guides FY08 EPS in-line, revs in-line (NICE) 31.57 : Reports Q4 (Dec) earnings of $0.39 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.38; revenues rose 21.1% year/year to $145.8 mln vs the $144.5 mln consensus. Co issues mixed guidance for Q1, sees EPS of $0.34-0.37 vs. $0.36 consensus; sees Q1 revs of $142-146 mln vs. $140.30 mln consensus. Co issues in-line guidance for FY08, sees EPS of $1.65-1.75 vs. $1.71 consensus; sees FY08 revs of $615-630 mln vs. $619.41 mln consensus. Q407 non-GAAP gross margin was 64.7%, up from 64.3% in Q406.
5:05AM On The Wires (WIRES) : HP (HPQ) and Unilever (UL) announce an extension of their relationship with the signing of a seven-year outsourcing contract for the management of Unilever's technology infrastructure in the Americas, Asia, Africa, Turkey and Middle East; contract is valued at $675 mln.
4:02AM On The Wires (WIRES) : Shire plc (SHPGY) announces that ELAPRASE, a human enzyme replacement therapy for the treatment of Hunter syndrome, has been approved for commercial sale by the Mexican Federal Commission for the Protection against Sanitary Risk.
4:00AM Advanced Semiconductor Engineering announces monthly net revenues (ASX) 4.10 : Co announces January consolidated net revenues increased 20.3% year/year to NT$ 8,592 mln. Sequential revenues decreased 7.1% year/year.
3:40AM Dassault Systems reports Q407 results (DASTY) 54.68 : Reports Q4 (Dec) earnings of EUR 0.78, excluding non-recurring items, EUR 0.06 better than the First Call consensus of EUR 0.72; revenues rose 5.1% year/year to EUR 371.1 mln vs the EUR 371.69 consensus. Co expects Q108 revenue of EUR 305-310 mln and EPS of EUR 0.40-0.42; co expects FY08 EPS of EUR 2.17-2.22. Co allocates EUR 35 mln for share buybacks.
3:20AM On The Wires (WIRES) : Omnicom Group (OMC) has acquired a majority interest in Shift, a digital consultancy in New Zealand... Amdocs (DOX) announces that Eagle Mobile, Albania's third mobile service provider, has selected the Amdocs Compact Convergence suite... NAVTEQ (NVT) announces an agreement with Telefonica for the cooperative innovation of new mobile traffic products for European markets... TeleCommunication Systems (TSYS) announces that Allion, an IT testing organization, will implement the TCS Xypoint Secure User Plane for Location Server to deliver Location-Based Services to Asia-Pacific customers.
3:18AM SCM Microsystems announces expected Q407 results (SCMM) 3.00 : Co announces expected results for Q407. Revenue is expected above the high end of management's previous guidance of $7.5 mln to $9.0 mln. Gross margin is expected above management's previous guidance of 40%. Revenue from continuing operations in Q407 is expected to be between $9.1 mln and $9.8 mln, above previous guidance of $7.5 mln to $9.0 mln. The expected improvement in revenue for Q407 vs previous guidance was due to additional sales of the PC Security products for U.S. government security programs and larger orders of Flash Media Reader products from a major customer. For FY08, co expects revenue growth between 25% and 35% from expected 2007 levels, resulting in total revenue of $37.0-$41.0 mln.
2:29AM Elan misses by $0.03, beats on revs (ELN) 25.14 : Reports Q4 (Dec) loss of $0.18 per share, excluding non-recurring items, $0.03 worse than the First Call consensus of ($0.15); revenues rose 31.2% year/year to $218.3 mln vs the $202.8 mln consensus. Total revenues are expected to grow by over 30% from the '07 level adn approach, if not exceed, $1.0 bln.
1:36AM Arcelor Mittal misses by $0.08, beats on revs (MT) 69.89 : Reports Q4 (Dec) earnings of $1.71 per share, $0.08 worse than the First Call consensus of $1.79; revenues rose 20.6% year/year to $27.99 bln vs the $26.7 bln consensus. Co expects Q108 Ebitda to be between $4.7 to $5.0 bln, comparable to Q407 levels.
1:30AM American Capital beats by $0.09, beats on revs; guides Q1 EPS below consensus (ACAS) 34.23 : Reports Q4 (Dec) earnings of $0.90 per share, $0.09 better than the First Call consensus of $0.81; revenues rose 104.6% year/year to $354 mln vs the $327.1 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.73-0.78 vs. $0.84 consensus. Co's board declares Q108 dividend of $1.01/share. Co reiterates its '08 dividend forecast of $4.19/share, a 13% growth over total '07 dividends of $3.72/share.
12:31AM Panera Bread beats by $0.04, reports revs in-line; guides Q1 EPS below consensus; guides Q2 (Jun) EPS in-line; guides FY08 EPS above consensus (PNRA) 35.91 : Reports Q4 (Dec) earnings of $0.59 per share, excluding non-recurring items, $0.04 better than the First Call consensus of $0.55; revenues rose 29.2% year/year to $300.8 mln vs the $303.7 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.36-0.42 vs. $0.50 consensus. Co issues in-line guidance for Q2 (Jun), sees EPS of $0.37-0.43 vs. $0.40 consensus. Co issues upside guidance for FY08, sees EPS of $2.00-2.11 vs. $1.97 consensus. In addition, co anticipates EPS of $1.22-1.32 for Q308 and Q408.
12:22AM BWAY Holding reports EPS in-line, beats on revs; guides Q2 EPS below consensus; guides FY08 EPS above consensus (BWY) 10.04 : Reports Q1 (Dec) loss of $0.18 per share, in-line with the First Call consensus of ($0.18); revenues rose 7.4% year/year to $217.4 mln vs the $212.5 mln consensus. Co issues downside guidance for Q2, sees EPS of $0.10-0.15, includes stock-based comp vs. $0.24 consensus. Co issues upside guidance for FY08, sees EPS of $0.68-0.78, includes stock-based comp, vs. $0.61 consensus.
12:16AM Vertex Pharma prices its 6.0 mln share offering at $17.14/share; announces agreement to issue convertible senior subordinated notes (VRTX) 17.14 : Co announces, concurrent with its agreement to sell shares of common stock, that it has entered into an agreement to sell $250.0 mln aggregate principal amount of 4.75% convertible senior subordinated notes due 2013.
12:11AM Vista Gold announces proposed $32 mln private placement (VGZ) 5.25 : Co announces they intend to offer up to $32 mln in aggregate principal amount of senior secured convertible notes pursuant to a brokered private placement. The Notes will be convertible into common shares at any time at the option of the holder at a conversion price of $6.00 per share, subject to adjustment in certain circumstances, including if the common shares are trading on the AMEX at less than US$5.00 on the first anniversary of the date of issuance of the Notes, or if VGZ issues common shares, or securities convertible into common shares, at a price of less than $6.00 during the term of the Notes, subject to a minimum conversion price of $4.80. The Notes will carry a coupon of 10% per annum and will mature 3 years from the date of issuance.
Copyright © 2008 Yahoo! All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Send Feedback
Copyright © 2008 Briefing.com All rights reserved. Copyright © 2008 Briefing.com All rights reserved.
*
*
*
*
*
*
*
*
*
* |
